$303,999,997
to ADVANCED TECHNOLOGY INTERNATIONAL
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds commercial-scale production of pharmaceutical drug substances and products under the BIOMAP consortium for medical preparedness.
Establishes domestic manufacturing capacity for critical drugs, reducing reliance on foreign suppliers during public health emergencies.
Signals investment in U.S. pharmaceutical manufacturing infrastructure and domestic supply chain resilience for active pharmaceutical ingredients and finished drug products.
Addresses strategic vulnerability in pharmaceutical manufacturing by building domestic production capacity independent of foreign supply chains.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-19. Cost: $0.002910.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75A50124F61002_7505_75A50123D00003_7505.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.